Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on American Tech Today.
Press releases published on April 15, 2025

Neuphoria Provides a Review of 2024 and Highlights 2025 Plans
Initiation by Merck of a Phase 2 trial in Alzheimer’s disease with partnered α7 nicotinic acetylcholine receptor PAM MK-1167 highlights company’s pipeline diversification beyond BNC210 US $15M milestone payment from Merck extends company’s cash runway to …

Lisata Therapeutics Announces Research License with Catalent
BASKING RIDGE, N.J., April 15, 2025 (GLOBE NEWSWIRE) -- Lisata Therapeutics, Inc. (Nasdaq: LSTA) (“Lisata” or the “Company”), a clinical-stage pharmaceutical company developing innovative therapies for the treatment of advanced solid tumors and other …

IPG Photonics to Announce First Quarter 2025 Financial Results on May 6
MARLBOROUGH, Mass., April 15, 2025 (GLOBE NEWSWIRE) -- IPG Photonics Corporation (Nasdaq: IPGP) will release its first quarter 2025 financial results before the market opens on Tuesday, May 6, 2025. The Company will hold a conference call to review these …

ORYZON Announces First Patient Dosed in NCI-Sponsored Phase I/II Clinical Trial of Iadademstat Plus Immune Checkpoint Inhibitors in 1L Extensive Stage Small Cell Lung Cancer
In combination with atezolizumab or durvalumab Study conducted under the CRADA agreement between NCI and Oryzon MADRID and CAMBRIDGE, Mass., April 15, 2025 (GLOBE NEWSWIRE) -- Oryzon Genomics, S.A. (ISIN Code: ES0167733015, ORY), a clinical-stage …

Pipe Acquires Glean.ai to Add Spend Management to Suite of Embedded Financial Solutions
SAN FRANCISCO, April 15, 2025 (GLOBE NEWSWIRE) -- Pipe, a fintech company enabling embedded financial solutions for software platforms, today announced its strategic acquisition of Glean.ai, a leading AI-powered spend management company. With this …

Processa Pharmaceuticals’ Dr. David Young to Present at World Orphan Drug Congress USA 2025
HANOVER, Md., April 15, 2025 (GLOBE NEWSWIRE) -- Processa Pharmaceuticals, Inc. (Nasdaq: PCSA) (Processa or the Company), a clinical-stage pharmaceutical company focused on developing the next generation cancer therapies with improved efficacy and safety, …

LyondellBasell baut seine Führungsrolle im Bereich Nachhaltigkeit im Nachhaltigkeitsbericht 2024 aus: From Vision to Value (Von der Vision zum Wert)
HOUSTON, April 15, 2025 (GLOBE NEWSWIRE) -- LyondellBasell (NYSE: LYB), ein weltweit führendes Unternehmen der chemischen Industrie, hat heute seinen Nachhaltigkeitsbericht 2024 veröffentlicht, in dem bedeutende Fortschritte bei zirkulären und …

LyondellBasell promueve el liderazgo en sostenibilidad en el Informe de Sostenibilidad 2024: De la visión al valor
HOUSTON, April 15, 2025 (GLOBE NEWSWIRE) -- LyondellBasell (NYSE: LYB), un líder mundial en el sector de química, publicó hoy su Informe de Sostenibilidad 2024, que muestra un progreso significativo en soluciones circulares y bajas en carbono, acción …

RAPT Therapeutics Deepens Expertise in Allergic Diseases with Appointment of Jessica Savage, M.D., M.H.S., as Vice President, Clinical Development
SOUTH SAN FRANCISCO, Calif., April 15, 2025 (GLOBE NEWSWIRE) -- RAPT Therapeutics, Inc. (Nasdaq: RAPT), a clinical-stage, immunology-based biopharmaceutical company focused on discovering, developing and commercializing novel therapies for patients living …

Combating Document Fraud and Transnational Crime: Lao PDR Airport Deploys Regula 4306 Comparator
RESTON, Va., April 15, 2025 (GLOBE NEWSWIRE) -- The space-saving yet full-function video spectral comparator Regula 4306 has been deployed at Wattay International Airport in Vientiane, the Lao People’s Democratic Republic, to strengthen the country’s …

FluidForm Bio™ Advances Vascularized Tissue Engineering with New FRESH™ 3D Bioprinting Breakthrough
WALTHAM, Mass., April 15, 2025 (GLOBE NEWSWIRE) -- FluidForm Bio™, a leader in cell therapies for chronic diseases such as type 1 diabetes, today announced a major advancement in vascularized tissue engineering. A newly published study in ACS Biomaterials …

LyondellBasell renforce son leadership en matière de durabilité dans son Rapport sur le développement durable 2024 : From Vision to Value (De la vision à la valeur)
HOUSTON, 15 avr. 2025 (GLOBE NEWSWIRE) -- LyondellBasell (NYSE : LYB), l’un des leaders mondiaux de l’industrie chimique, a publié aujourd’hui son Rapport sur le développement durable 2024, démontrant des progrès significatifs en matière de solutions …

LyondellBasell avança na liderança em sustentabilidade no Relatório de Sustentabilidade de 2024: Da Visão ao Valor
HOUSTON, April 15, 2025 (GLOBE NEWSWIRE) -- A LyondellBasell (NYSE: LYB), líder global na indústria química, divulgou hoje seu Relatório de Sustentabilidade de 2024, demonstrando progresso significativo em soluções circulares e de baixo carbono, ação …

LyondellBasell rafforza la leadership in materia di sostenibilità con il suo Rapporto di Sostenibilità 2024: “From Vision to Value”
HOUSTON, April 15, 2025 (GLOBE NEWSWIRE) -- LyondellBasell (NYSE: LYB), leader globale nell'industria chimica, ha pubblicato oggi il suo Rapporto sulla Sostenibilità 2024, confermando progressi significativi nell’ambito delle soluzioni circolari e a basse …

LyondellBasell versterkt duurzaam leiderschap in Duurzaamheidsrapport 2024: van visie naar waarde
HOUSTON, April 15, 2025 (GLOBE NEWSWIRE) -- LyondellBasell (NYSE: LYB), een leider in de wereldwijde chemische industrie, heeft vandaag zijn duurzaamheidsrapport van 2024 gepubliceerd, waarin staat dat er aanzienlijke vooruitgang is geboekt in circulaire …

利安德巴赛尔 2024 年可持续发展报告彰显可持续发展领导力:从愿景到价值
休斯顿, April 15, 2025 (GLOBE NEWSWIRE) -- 全球化⼯⾏业的头部企业利安德巴赛尔 (NYSE: LYB) 今天发布了 2024 年可持续发展报告:从愿景到价值 (2024 Sustainability Report: From Vision to Value) ,展示其在循环和低碳解决⽅案、⽓候⾏动和卓越运营⽅⾯取得的重⼤进展。 利安德巴赛尔⾸席执⾏官 Peter Vanacker 表示:“在 LYB,可持续发展是重新构想未来和创造⻓期价值的机会。2024 …

zSpace Acquires Second Avenue Learning to Revolutionize Experiential Education
SAN JOSE, Calif., April 15, 2025 (GLOBE NEWSWIRE) -- zSpace, Inc., a leading provider of augmented and virtual reality (AR/VR) solutions for education, proudly announces the acquisition of Second Avenue Learning, a Rochester, NY-based innovator in …

Tectonic Therapeutic to Present Phase 1b Data for TX45 at European Society of Cardiology Heart Failure 2025
WATERTOWN, Mass., April 15, 2025 (GLOBE NEWSWIRE) -- Tectonic Therapeutic, Inc. (NASDAQ: TECX) (“Tectonic”), a clinical stage biotechnology company focused on the discovery and development of therapeutic proteins and antibodies that modulate the activity …

AgEagle Showcases eBee VISION Drone at 173rd Airborne Brigade Innovation Symposium
Private event featured demonstrations and roundtable discussions with key members of the armed forces and key decision makers WICHITA, Kan., April 15, 2025 (GLOBE NEWSWIRE) -- AgEagle Aerial Systems Inc. (NYSE: UAVS) (“AgEagle” or the “Company”), a leading …

Aspargo Labs CEO to Participate in Panel Discussion at the American Urological Association Innovation Nexus Conference
NEW YORK, April 15, 2025 (GLOBE NEWSWIRE) -- Aspargo Labs, Inc. ("Aspargo Labs" or the "Company"), a Pharmaceutical and MedTech company focused on converting the world's most meaningful medications into liquid oral suspensions for delivery in proprietary …